期刊文献+

原发性肝脏淋巴瘤的诊疗进展 被引量:5

Diagnosis and treatment progress on primary hepatic lymphoma
下载PDF
导出
摘要 原发性肝脏淋巴瘤为原发并局限于肝脏的非霍奇金淋巴瘤,是一类相对罕见的肝脏疾病,多见于中老年男性,其发生机制可能与肝脏慢性炎症、免疫功能受损以及基因畸变等因素有关。原发性肝脏淋巴瘤的病理组织学类型以弥漫性大B细胞淋巴瘤为主。该类患者除了少数表现有右上腹疼痛外,无典型的临床表现。常规影像学检查较难识别,确诊依赖于病理学检查。手术切除病灶联合术后辅助化疗可以提高患者预后。临床上对原发性肝脏淋巴瘤的诊断及治疗尚无统一标准,常常被误诊。本文根据国内外文献,就原发性肝脏淋巴瘤的诊治进展作一综述,以期提高临床医师对本病的诊疗水平。
作者 袁晨 梁磊 胡嘉钰 王莹 童向民 杨田 YUAN Chen;LIANG Lei;HU Jia-yu
出处 《肝胆胰外科杂志》 CAS 2021年第5期312-316,共5页 Journal of Hepatopancreatobiliary Surgery
基金 国家自然科学基金项目(82070212)。
  • 相关文献

参考文献6

二级参考文献34

  • 1吴宏菊,张清媛,陈德发,关小军,张伯龙,马军.美罗华联合CHOP方案与CHOP方案治疗初治弥漫性大B细胞淋巴瘤的临床对比研究[J].癌症,2005,24(12):1498-1502. 被引量:33
  • 2程月新,徐卫,李建勇,钱思轩,陆化,吴汉新,陈丽娟.非霍奇金淋巴瘤641例临床分析[J].南京医科大学学报(自然科学版),2006,26(9):837-840. 被引量:15
  • 3Vellenga E, van Putten WL, van' t Veer MB, et al. Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20 NHL: a prospective randomized HOVON trial[ J ]. Blood, 2008, 111 (2): 537-543.
  • 4E1 Gnaoui T, Dupuis J, Belhadj K, et al. Rituximab, gemcitabine and oxaliplatin: an effective salvage regimen for patients with relapsed or refractory B-cell lymphoma not candidates for high- dose therapy[J]. Ann Oncol, 2007,18(8): 1363-1368.
  • 5Arturo M. A decade of rituximab: improving survival outcomes in non-Hodgkin' s lymphoma [J]. Annu Rev Med, 2008, 59: 217-250.
  • 6Cheson BD, Homing S J, Coiffier B, et al. Report of an interna- tional workshop to standardize response criteria for non-Hodg- kin's lymphomas. NCI Sponsored International Working Group [J]. J Clin Oncol, 1999, 17(4): 1244.
  • 7Gregory SA, Trumoer L. Chemotherapy dose intensity in non- Hodgkin' s lymphoma: is dose intensity an emerging paradigm for better outcomes[J]. Ann Oncol, 2005, 16(9): 1413-1424.
  • 8Fisher RI, Miller TP, O' Connor OA. Diffuse aggressive lymphoma [J]. Hematology Am Soe Hematol Educ Program, 2004: 221-236.
  • 9Coiffier B, LePage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma [J]. N Engl J Med, 2002, 346 (4): 235-242.
  • 10Pfreundschuh M, Trumper L, Osterborg A, et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large B-cell lymphoma: a randomized controlled trial by Mab Thera International Trail (MINT) Group [J]. Lancet Oncol, 2006, 7 (5): 379-391.

共引文献50

同被引文献22

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部